Analysis of the in vitro activity of trovafloxacin (CP-99,219) against Bacteroides species

Infectious Diseases in Clinical Practice

Volumn 5, Issue SUPPL. 3, 1996, Pages

  Snydman, David R ^a   McDermott, Laura ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOXITIN; CIPROFLOXACIN; OFLOXACIN; TROVAFLOXACIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEROIDES; DRUG ACTIVITY; HUMAN; IN VITRO STUDY;

EID: 0029767419     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019048-199606001-00003     Document Type: Article

References (17)

1. Barry AL, Fuchs PC. In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacin. Antimicrob Agents Chemother 1991;35:955-60.
2. Goldstein EJ, Citron DM. Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-990, and WIN 57273 against anaerobic bacteria. Antimicrob Agents Chemother 1992;36:1158-62.
3. Goldstein EJC. Patterns of susceptibility to fluoroquinolones among anaerobic bacterial isolates in the United States. Clin Infect Dis 1993;16(4 Suppl):S5377-S81.
4. Brook I. In vivo efficacies of quinolones and clindamycin for treatment of infections with Bacteroides fragilis and/or Escherichia coli in mice: correlation with in vitro susceptibilities. Antimicrob Agents Chemother 1993;37: 997-1000.
5. Solomkin JS, Reinhart HH, Dellinger EP, et al. Results of a randomized trial comparing sequential intravenous/ oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. Ann Surg 1996;3:303-15.
6. Gooding BB, Jones RN. In vitro antimicrobial activity of CP-99,219, a novel azabicyclo-naphthridone. Antimicrob Agents Chemother 1993;37:349-53.
7. Spangler SK, Jacobs MR, Appelbaum PC. Activity of CP-99,219 compared to those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes. Antimicrob Agents Chemother 1994;38:2471-6.
8. Neu HC, Chin NX. In vitro activity of the new fluoroquinolone CP-99,219. Antimicrob Agents Chemother 1994;38: 2615-22.
9. Appelbaum PC, Spangler SK, Jacobs MR. β-Lactamase production and susceptibilities to amoxacillin, amoxacillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis bacteroides and 129 fusobacteria from 28 U.S. centers. Antimicrob Agents Chemother 1990;34:1546-50.
10. Snydman DR, Cuchural GJ Jr, The National Anaerobic Susceptibility Study Group. Susceptibility variations in Bacteroides fragilis: a national survey. Infect Dis Clin Pract 1994;3(1 Suppl):S34-S43.
11. Holdeman LV, Moore WEC. Anaerobic laboratory manual. 4th ed. Blacksburg: Virginia Polytechnic Institute and State University, 1977.
12. Summanen P, Baron EJ, Citron DM, Strong CA, Wexler H, Finegold SM. Wadsworth anaerobic bacteriology manual. 5th ed. Belmont (CA): Star Publishing Company, 1993.
13. National Committee for Clinical Laboratory Standards. Methods for antimicrobial susceptibility testing of anaerobic bacteria. 3rd ed. Approved standard M11-A3. Villanova (PA): NCCLS, 1993.
14. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. 5th informational supplement [document M100-S5J. Villanova (PA): NCCLS, 1994.
15. Gorbach SL, Bartlett JG. Anaerobic infections. N Engl J Med 1974;290:1177-84, 1237-45.
16. Hecht DW, Lederer L, Osmolski JR. Comparison of in vitro activity of levofloxacin to ofloxacin and ciprofloxacin against anaerobes using three media. In: Proceedings and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy [session 122]; Orlando, FL. Washington (DC): American Society for Microbiology, 1994:E61.
17. Snydman DR, Cuchural GJ, McDermott L, Gill M. Correlation of various in vitro testing methods with clinical outcomes in patients with Bacteroides fragilis group infections treated with cefoxitin: a retrospective analysis. Antimicrob Agents Chemother 1992;36:540-4.